New research shows psilocybin use rose after legalization and decriminalization efforts, especially in Oregon, while use of LSD and MDMA declined. This “substitution effect” suggests people may be choosing psilocybin over “riskier” substances. Researchers analyzed data from the Monitoring the Future project and found the policy reforms likely contributed to a shift toward mushrooms, which have a lower risk profile and growing therapeutic reputation.